A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride

March 13, 2018

A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride

Published on 03/12/2018

previous post: Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): An open-label, dose-finding and dose-expansion, phase 1b trial
next post: Death risk increased with two blood pressure drugs